Skip to main content
Clinical Trials/TCTR20181119002
TCTR20181119002Terminated未知

The role of childhood adversity in cortisol dysregulation in depressed and non-depressed methamphetamine users with and without history of suicide

none0 sites195 target enrollmentStarted: November 19, 2018Last updated:
Conditions

Trial Snapshot

Phase
未知
Status
Terminated
Sponsor
Enrollment
195

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Observational

Eligibility Criteria

Ages
18 Years to 65 Years (—)
Sex
All

Inclusion Criteria

  • (a) age of 18 to 65 years; (b) a history of at least two years of continuous consumption of methamphetamine by a vapor inhalation model about 0.5 to 1 g/day; (c) a diagnosis of drug dependence and MDD based on DSM-5 criteria and history of suicide attempt in the past or the existence of suicidal ideation in the last 12 months; (d) being in the abstinence phase for at least six and not more than 12 months and the presence of PAWS in the depressed group; (e) the history of suicide attempt at least once and at most three times; (f) body mass index (BMI) between 18 and 35 kg; and (g) lack of suicide attempts and suicidal ideation in the control group.

Exclusion Criteria

  • (a) history of seizure, head trauma, endocrine disruptions, cardiovascular disease or other specific chronic diseases; (b) treatment in the last 6 months with antidepressants, neuroleptics, sedatives, glucocorticoids, appetite suppressants, estrogens, dopamine medications; (c) Experience of any extraordinary stress at present; and (d) pregnancy, hormone intake, or any cortisol simulants or suppressants. Money was paid to people for their contributions.

Investigators

Sponsor
none

Similar Trials